BMS hires Roche's Mike Burgess
This article was originally published in Scrip
Executive Summary
Bristol-Myers Squibb has appointed Roche's Mike Burgess senior vice-president of discovery medicine and clinical pharmacology. Prior to joining BMS Mr Burgess served as interim head of research and early development at Roche – a position now occupied by John Reed (scripintellignce.com, 16 January 2013). In his new role, Mr Burgess will report to Francis Cuss, senior vice-president research, R&D, and will be a member of BMS' research senior leadership team.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.